Prescrire Int. 1999 Aug;8(42):107-9.
(1) This codeine-based syrup is indicated for the treatment of pain in children. It is the first step 2 analgesic (WHO classification) to become available in France for oral treatment of children. (2) Efficacy and the optimal dose regimen are based mainly on lengthy experience with codeine in other countries. Only a few small trials on acute pain are available. (3) The safety profile is that of all opiates: adverse effects comprise mainly constipation, nausea and vomiting. (4) Accidental ingestion by a young child can lead to severe poisoning.
(1) 这种含可待因的糖浆用于治疗儿童疼痛。它是法国第一种可用于儿童口服治疗的2级镇痛药(世界卫生组织分类)。(2) 疗效和最佳剂量方案主要基于其他国家使用可待因的长期经验。仅有少数关于急性疼痛的小型试验。(3) 安全性与所有阿片类药物相同:不良反应主要包括便秘、恶心和呕吐。(4) 幼儿意外摄入可导致严重中毒。